Key Findings:  Resulting data led the authors to conclude that terpene-encapsulated poly(ethylene glycol)-poly(lactic-co-glycolic acid) nanoparticles (i.e., β-myrcene, β-caryophyllene, and nerolidol) may be novel therapeutics compounds in the treatment of chronic pain.
Type of Study:  Laboratory Study
Study Result:  Positive
Study Location(s):  Spain, United States
Year of Pub:  2022
Cannabinoids Studied: 
Phytocannabinoid Source:  Not Applicable
Terpenes Studied:  ß-Caryophyllene, Myrcene, Nerolidol
Receptors Studied:  TRPV1